These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26328518)
1. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review. Ge Y; Zhou H; Shi J; Ye B; Peng Q; Lu X; Wang G Clin Rheumatol; 2015 Dec; 34(12):2097-103. PubMed ID: 26328518 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. Kurita T; Yasuda S; Oba K; Odani T; Kono M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Atsumi T Rheumatology (Oxford); 2015 Jan; 54(1):39-44. PubMed ID: 24764266 [TBL] [Abstract][Full Text] [Related]
3. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis. Kurita T; Yasuda S; Amengual O; Atsumi T Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551 [TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis. Yokoyama Y; Furuta S; Ikeda K; Hirose K; Nakajima H Mod Rheumatol; 2015; 25(6):888-92. PubMed ID: 25775144 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of tacrolimus in patients with dermatomyositis/polymyositis: A meta-analysis and systematic review. Liao J; Peng X; Liu J; Xie X; Wang J Eur J Intern Med; 2023 Apr; 110():35-40. PubMed ID: 36725399 [TBL] [Abstract][Full Text] [Related]
7. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. Fathi M; Barbasso Helmers S; Lundberg IE J Intern Med; 2012 Jun; 271(6):589-97. PubMed ID: 21950266 [TBL] [Abstract][Full Text] [Related]
8. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial. Takada K; Katada Y; Ito S; Hayashi T; Kishi J; Itoh K; Yamashita H; Hirakata M; Kawahata K; Kawakami A; Watanabe N; Atsumi T; Takasaki Y; Miyasaka N Rheumatology (Oxford); 2020 May; 59(5):1084-1093. PubMed ID: 31539061 [TBL] [Abstract][Full Text] [Related]
9. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887 [TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population. Unger L; Kampf S; Lüthke K; Aringer M Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995 [TBL] [Abstract][Full Text] [Related]
11. Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature. Matsubara S; Kondo K; Sugaya K; Miyamoto K Clin Rheumatol; 2012 Oct; 31(10):1493-8. PubMed ID: 22886003 [TBL] [Abstract][Full Text] [Related]
12. Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study. Shimojima Y; Ishii W; Matsuda M; Tazawa K; Ikeda S BMC Musculoskelet Disord; 2012 Nov; 13():228. PubMed ID: 23173570 [TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review. Wang DX; Shu XM; Tian XL; Chen F; Zu N; Ma L; Wang GC Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797 [TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis. Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K Lung; 2009; 187(3):201-6. PubMed ID: 19387736 [TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020 [TBL] [Abstract][Full Text] [Related]
16. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. Sharma N; Putman MS; Vij R; Strek ME; Dua A J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644 [TBL] [Abstract][Full Text] [Related]
17. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. Nagashima T; Minota S Rheumatology (Oxford); 2015 Jun; 54(6):1128-9. PubMed ID: 25832615 [No Abstract] [Full Text] [Related]
18. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply. Yasuda S; Kurita T; Horita T; Atsumi T Rheumatology (Oxford); 2015 Jun; 54(6):1129. PubMed ID: 25832614 [No Abstract] [Full Text] [Related]
19. Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders. Gordon P; Gooptu B Rheumatology (Oxford); 2015 Jan; 54(1):3-4. PubMed ID: 25342374 [No Abstract] [Full Text] [Related]
20. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Takada K; Nagasaka K; Miyasaka N Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]